These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 20479737)

  • 1. The chemotherapy of malignant melanoma.
    Wick MM
    J Invest Dermatol; 1983 Jun; 80(1 Suppl):61s-2s. PubMed ID: 20479737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The chemotherapy of malignant melanoma.
    Wick MM
    J Invest Dermatol; 1983 Jun; 80 Suppl():61s-62s. PubMed ID: 6854056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium ascorbate enhancement of carbidopa-levodopa methyl ester antitumor activity against pigmented B16 melanoma.
    Pierson HF; Meadows GG
    Cancer Res; 1983 May; 43(5):2047-51. PubMed ID: 6831435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levodopa and dopamine analogs: dihydroxy and trihydroxybenzylamines as novel quinol antitumor agents in experimental leukemia in vivo.
    Wick MM
    Cancer Treat Rep; 1981; 65(9-10):861-7. PubMed ID: 7273019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of peroxidation in murine melanoma by dietary tyrosine-phenylalanine restriction, levodopa methylester chemotherapy, and sodium ascorbate supplementation.
    Pierson HF; Meadows GG
    J Natl Cancer Inst; 1985 Sep; 75(3):507-16. PubMed ID: 3861901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levodopa and dopamine analogs as DNA polymerase inhibitors and antitumor agents in human melanoma.
    Wick MM
    Cancer Res; 1980 May; 40(5):1414-8. PubMed ID: 6768447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benserazide decreases central AADC activity, extracellular dopamine levels and levodopa decarboxylation in striatum of the rat.
    Jonkers N; Sarre S; Ebinger G; Michotte Y
    J Neural Transm (Vienna); 2001; 108(5):559-70. PubMed ID: 11459076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levodopa/carbidopa/entacapone in Parkinson's disease.
    Seeberger LC; Hauser RA
    Expert Rev Neurother; 2009 Jul; 9(7):929-40. PubMed ID: 19589043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect.
    Prescrire Int; 2005 Apr; 14(76):51-4. PubMed ID: 15875340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of therapy on the antioxidant status in patients with melanoma.
    Gadjeva V; Dimov A; Georgieva N
    J Clin Pharm Ther; 2008 Apr; 33(2):179-85. PubMed ID: 18315784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic effect of dopamine infusion on human malignant melanoma.
    Wick MM
    Cancer Treat Rep; 1982 Aug; 66(8):1657-9. PubMed ID: 7105057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levodopa/carbidopa intestinal gel infusion in advanced Parkinson's disease: a 7-year experience.
    Zibetti M; Merola A; Artusi CA; Rizzi L; Angrisano S; Reggio D; De Angelis C; Rizzone M; Lopiano L
    Eur J Neurol; 2014 Feb; 21(2):312-8. PubMed ID: 24313838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Optimization of use of levodopa in Parkinson's disease: role of levodopa-carbidopa-entacapone combination].
    Castro A; Valldeoriola F; Linazasoro G; Rodriguez-Oroz MC; Stochi F; Marin C; Rodriguez M; Vaamonde J; Jenner P; Alvarez L; Pavon N; Macias R; Luquin MR; Hernandez B; Grandas F; Gimenez-Roldan S; Tolosa E; Obeso JA
    Neurologia; 2005 May; 20(4):180-8. PubMed ID: 15891947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raspberry pulp polysaccharides inhibit tumor growth via immunopotentiation and enhance docetaxel chemotherapy against malignant melanoma in vivo.
    Yang YJ; Xu HM; Suo YR
    Food Funct; 2015 Sep; 6(9):3022-34. PubMed ID: 26200777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levodopa-carbidopa may improve vision loss in indirect traumatic optic neuropathy.
    Razeghinejad MR; Rahat F; Bagheri M
    J Neurotrauma; 2010 Oct; 27(10):1905-9. PubMed ID: 20649490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with levodopa and risk for malignant melanoma.
    Olsen JH; Tangerud K; Wermuth L; Frederiksen K; Friis S
    Mov Disord; 2007 Jul; 22(9):1252-7. PubMed ID: 17534943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel dopamine releasing response of an anti-convulsant agent with possible anti-Parkinson's activity.
    Gluck MR; Santana LA; Granson H; Yahr MD
    J Neural Transm (Vienna); 2004 Jun; 111(6):713-24. PubMed ID: 15168218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tamoxifen in the treatment of metastatic malignant melanoma: still a controversy? (Review).
    Toma S; Ugolini D; Palumbo R
    Int J Oncol; 1999 Aug; 15(2):321-37. PubMed ID: 10402244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine agonist cabergoline inhibits levodopa-induced caspase activation in 6-OHDA-lesioned mice.
    Tanaka K; Ogawa N
    Neurosci Res; 2005 Jan; 51(1):9-13. PubMed ID: 15596235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.